Evidence map›Paper›PMID 29554042›Full record

Trial reportThe journal of trauma and acute care surgery2018

Effects of platelet-sparing leukocyte reduction and agitation methods on in vitro measures of hemostatic function in cold-stored whole blood.

Kenneth E Remy, Mark H Yazer, Arun Saini, Ajlana Mehanovic-Varmaz, Sharon R Rogers, Andrew P Cap, Philip C Spinella

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The journal of trauma and acute care surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kenneth E RemyFrom the Division of Pediatric Critical Care Medicine, Department of Pediatrics (K.E.R., A.M-V., S.R.R., P.C.S.), Washington University School of Medicine, St. Louis, Missouri; Institute for Transfusion Medicine (M.H.Y.), University of Pittsburgh, Pittsburgh, Pennsylvania; Division of Pediatric Critical Care Medicine, Department of Pediatrics (A.S.), The University of Tennessee Health Science Center, Memphis, Tennessee; and Coagulation and Blood Research Program (A.P.C., P.C.S.), United States Army Institute of Surgical Research; Ft Sam Houston, Texas.
Mark H Yazer
Arun Saini
Ajlana Mehanovic-Varmaz
Sharon R Rogers
Andrew P Cap
Philip C Spinella

Funding

Impact of Red Blood Cell (RBC)-Derived DAMPs on Host Immune Response in Pediatric SepsisK08GM129763 · NIGMS · WASHINGTON UNIVERSITY · PI REMY, KENNETH EUGENE · 2018 to 2021
$714k
NICHD NIH HHS L40 HD089386NIGMS NIH HHS K08 GM129763
6 · The paper itself

Abstract

backgroundAgitation of platelet units stored at room temperature is performed routinely to maintain platelet function, and leukoreduction of blood products is the standard of care in many countries to reduce immune consequences of transfusion. The effect of agitation and leukoreduction on whole blood stored at 4°C requires investigation, as reductions in hemostatic capacity of whole blood may reduce its efficacy in treating trauma-induced coagulopathy and platelet dysfunction. We hypothesize that agitation of whole blood will not affect hemostatic function and that leukoreduction will reduce hemostatic function of whole blood.

methodsIn this in vitro randomized controlled study, 21 units of leukoreduced and 20 nonleukoreduced whole blood units were each randomly assigned into four agitation groups. Hemostatic parameters were measured using viscoelastic assays (rotational thromboelastometry-Extrinsic Screening Test (ROTEM-EXTEM) and thromboelastography (TEG) platelet mapping), impedance aggregometry (agonists-adenosine phosphate, arachidonic acid, thrombin receptor activating peptide, and collagen), and a thrombin generation assay from these whole blood units before and after filtration and on 0, 5, 10, and 15 days of storage at 4°C.

resultsLeukoreduction compared to nonleukoreduction reduced platelet concentration on Day 0. Viscoelastic measures and thrombin generation parameters revealed significant reduction in hemostatic function between the leukoreduced units and the nonleukoreduced units at a few time points. Leukoreduced units consistently demonstrated reduced platelet aggregation compared to the nonleukoreduced units. Agitation methods did not significantly affect any of the hemostatic parameters examined.

conclusionsLeukoreduction of whole blood with a platelet-sparing filter caused a moderate but significant reduction in some measures of whole blood hemostatic function most evident early in storage. The benefits of leukoreduction should be weighed against the potential reduced hemostatic function of leukoreduced units. Agitation of whole blood is not required to maintain hemostatic function. LEVEL OF EVIDENCE: In vitro randomized controlled trial, level 1.

Indexed as

HemostasisLeukocyte Reduction ProceduresBlood PlateletsBlood PreservationCold TemperatureHumansIn Vitro TechniquesPlatelet AggregationThrombelastographyThrombinThrombin

Identifiers

PMID29554042
PMCPMC8242931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.